The Supreme Court sided with Roche Molecular Systems over Stanford University in a patent dispute for an HIV testing kit that uses polymerase chain reaction (PCR) technology. Dr Mark Holodniy, a fellow at Stanford University and inventor of the PCR technology, was assigned by the university to conduct research at Cetus.
The Supreme Court sided with Roche Molecular Systems over Stanford University in a patent dispute for an HIV testing kit that uses polymerase chain reaction (PCR) technology. Dr Mark Holodniy, a fellow at Stanford University and inventor of the PCR technology, was assigned by the university to conduct research at Cetus. While there, he signed a contract assigning any inventions arising from his time there to Cetus; he signed a similar agreement with Stanford. Roche acquired Cetus’s rights to the test and developed and commercialized a widely used kit; Stanford sued for patent infringement.
Stanford argued that Dr Holodniy could not assign rights to Cetus due to the Bayh-Dole Act, which deals with intellectual property arising from federally funded research.
Vote in the poll and share your comments with colleagues below.
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More